Pre-operative clonal hematopoiesis is related to adverse outcome in lung cancer after adjuvant therapy

Jae Kwang Yun, Sugyeong Kim, Hongyul An, Geun Dong Lee, Hyeong Ryul Kim, Yong-Hee Kim, Dong Kwan Kim, Seung-Il Park, Sehoon Choi, Youngil Koh · 2023

Read Pre-operative clonal hematopoiesis is related to adverse outcome in lung cancer after adjuvant therapy by Jae Kwang Yun, Sugyeong Kim, Hongyul An, Geun Dong Lee, Hyeong Ryul Kim, Yong-Hee Kim, Dong Kwan Kim, Seung-Il Park, Sehoon Choi, Youngil Koh (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10714617.txt.

Description

Jae Kwang Yun and nine co-authors study a blood condition's effect on lung cancer outcomes, in a 2023 paper. The condition, clonal hematopoiesis, means some blood stem cells carry shared mutations. It often grows after chemotherapy or radiation, and its effect on later cancer care was unclear.

The team tested blood taken before surgery from 415 lung cancer patients who then had further treatment. About a fifth carried the mutations. Those patients died sooner on average than patients without them, even after careful matching and adjustment for other factors. Early-stage patients showed the same pattern. The authors suggest that a simple blood check before surgery could flag patients who need closer watch after treatment.

Catalog record

CREATORJae Kwang Yun, Sugyeong Kim, Hongyul An, Geun Dong Lee, Hyeong Ryul Kim, Yong-Hee Kim, Dong Kwan Kim, Seung-Il Park, Sehoon Choi, Youngil Koh
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE36 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10714617

Browse the full library · About the Tower of Babel